KETV: Methodist Offering Unique Lung Cancer Clinical Trial

Lung cancer accounts for about 27% of all cancer deaths and is by far the leading cause of cancer death among both men and women according to the American Cancer Society.

A one of a kind clinical trial here in Omaha at Methodist Estabrook Cancer Center is exploring new treatment options for Stage 4 lung cancer patients.

Dr. Robert Langdon, Nebraska Cancer Specialists, spoke with KETV reporter Jobeth Devera about the clinical trial available at Methodist Estabrook Cancer Center and only 14 other sites in the U.S.